Research programme: bioactive lipid-based therapeutics - Ono Pharmaceutical/Tohoku University/University of Tokyo

Drug Profile

Research programme: bioactive lipid-based therapeutics - Ono Pharmaceutical/Tohoku University/University of Tokyo

Latest Information Update: 13 Mar 2014

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Ono Pharmaceutical; Tohoku University; University of Tokyo
  • Class Lipids
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Research Unspecified

Most Recent Events

  • 13 Mar 2014 Research programme: bioactive lipid-based therapeutics - Ono Pharmaceutical/Tohoku University/University of Tokyo is available for licensing in World as of 13 Mar 2014. http://www.ono.co.jp
  • 06 Mar 2014 Early research in Undefined indication in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top